PTC Therapeutics | PTCT - ДОЛГ





ДОЛГ Изменить Дата
Acadia Pharmaceuticals USD 73.85M 23.06M 2026-06
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
Amgen USD 57.3B 19M 2026-06
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 7.69B 398.3M 2026-09
BioMarin Pharmaceutical USD 4.19B 11.99M 2026-09
Cytokinetics USD 1.27B 18.17M 2026-06
Daiichi Sankyo JPY 500.48B 200B 2026-06
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Gilead Sciences USD 26.25B 4.07B 2026-06
Incyte USD 38.27M 1.16M 2026-06
Ionis Pharmaceuticals USD 1.77B 141M 2026-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 62.67B 523M 2026-09
PTC Therapeutics USD 2.84B 2.15B 2026-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 857.36M 188.48M 2026-09
TG Therapeutics USD 754.44M 884K 2026-06
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 6.48B 4.5B 2026-09
Xencor USD 170.11M 5.06M 2026-06